Latino Teen Depression Treatment Study

Sponsor
Duke University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05499182
Collaborator
(none)
35
6.9

Study Details

Study Description

Brief Summary

Despite experiencing higher rates of depressive symptoms (Center for Disease Control and Prevention, 2020) and similar rates of Major Depressive Disorder (MDD; Substance Abuse and Mental Health Services Administration (SAMHSA), 2019), Latino adolescents in the U.S. are significantly less likely than their non-Latino White peers to receive treatment for MDD (SAMHSA, 2019). The purpose of this study is to identify a stakeholder-preferred implementation strategy that may improve psychotherapy attendance among Latino adolescents. Latino adolescent-parent dyads and healthcare providers will be recruited from healthcare settings and social media. Focus groups will be conducted with healthcare providers (n=5), and individual interviews will be conducted with Latino adolescents with a diagnosis of depression (n=15) and their parents (n=15).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    35 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Identification of Implementation Strategies to Promote Depression Treatment Use Among Latino Adolescents
    Anticipated Study Start Date :
    Sep 1, 2022
    Anticipated Primary Completion Date :
    Mar 31, 2023
    Anticipated Study Completion Date :
    Mar 31, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Teens

    Teens are: 1) Male 2) Aged 13-17; 3) self-identified as Hispanic/Latino; 4) diagnosed with Major Depressive Disorder or Persistent Depressive Disorder/Dysthymia; and 5) referred to psychotherapy or prescribed medication for depression. Teens will be excluded if they are experiencing intense psychological distress or imminent thoughts of suicide.

    Parents

    Parents will 1) Be parents or legal guardians of teens; and 2) Speak and read English or Spanish.

    Healthcare Providers

    Healthcare providers will 1) Self-identify as regularly providing clinical care to Latino adolescents with depression; and 2) be in a role in which they can refer to or provide depression treatment.

    Outcome Measures

    Primary Outcome Measures

    1. Preferred implementation strategy to improve depression treatment use generated from qualitative interviews/focus groups [Baseline]

      Implementation strategy preference options will include: 1) Near Peer Depression Support Groups; 2) Parent-Teen Depression Treatment Activation Training; and 3) Depression Care Navigation Services. We will determine which strategy is most preferred by asking stakeholders, "Which of these strategies would work best for you/your family/Latino teens?" We will add up the responses to determine the preferred strategy with the highest frequency.

    Secondary Outcome Measures

    1. Number of barriers to depression treatment use generated from qualitative interviews/focus groups [Baseline]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria for Teens:
    • Male gender

    • Aged 13-17 years

    • Diagnosed with Major Depressive Disorder or Persistent Depressive Disorder

    • Referred to psychotherapy and/or prescribed antidepressant medications for depression

    Exclusion Criteria for Teens:
    • Experiencing imminent thoughts of self-harm or suicide

    • Experiencing acute psychological distress (e.g., uncontrolled crying)

    Inclusion Criteria for Parents:
    • Parent or legal guardian of teen

    • Able to read and speak English or Spanish

    Exclusion Criteria for Parents:
    • Unable to read/speak English or Spanish
    Inclusion Criteria for Healthcare Providers:
    • Self-identification as regularly providing clinical care to Latino adolescents with depression

    • Be in a role in which they can provide or refer patients to depression treatment

    Exclusion Criteria for Healthcare Providers

    • Unable to provide or refer to depression treatment

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Duke University

    Investigators

    • Principal Investigator: Allison M Stafford, PhD, Duke University School of Nursing

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Duke University
    ClinicalTrials.gov Identifier:
    NCT05499182
    Other Study ID Numbers:
    • Pro00110026
    First Posted:
    Aug 12, 2022
    Last Update Posted:
    Aug 12, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Duke University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 12, 2022